Institution: | (1) Australian Nuclear Science and Technology Organisation (ANSTO), Radiopharmaceuticals Research Institute (RRI), PMB 1, Menai, NSW, 2234 Sydney, NSW, Australia;(2) Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), Sydney, NSW, Australia;(3) Department of Biomedical Science, University of Wollongong, Wollongong, NSW, Australia |